Authors:
BESSARD ACH
GARAY E
LACRONIQUE V
LEGROS Y
DEMARQUAY C
HOUQUE A
PORTEFAIX JM
GRANIER C
SOUSSI T
Citation: Ach. Bessard et al., REGULATION OF THE SPECIFIC DNA-BINDING ACTIVITY OF XENOPUS-LAEVIS P53- EVIDENCE FOR CONSERVED REGULATION THROUGH THE CARBOXY-TERMINUS OF THE PROTEIN, Oncogene, 16(7), 1998, pp. 883-890
Authors:
SHIMIZU S
EGUCHI Y
KAMIIKE W
FUNAHASHI Y
MIGNON A
LACRONIQUE V
MATSUDA H
TSUJIMOTO Y
Citation: S. Shimizu et al., BCL-2 PREVENTS APOPTOTIC MITOCHONDRIAL DYSFUNCTION BY REGULATING PROTON FLUX, Proceedings of the National Academy of Sciences of the United Statesof America, 95(4), 1998, pp. 1455-1459
Authors:
BERGER R
LECONIAT M
LACRONIQUE V
DANIEL MT
LESSARD M
BERTHOU C
MARYNEN P
BERNARD O
Citation: R. Berger et al., CHROMOSOME-ABNORMALITIES OF THE SHORT ARM OF CHROMOSOME-12 IN HEMATOPOIETIC MALIGNANCIES - A REPORT INCLUDING 3 NOVEL TRANSLOCATIONS INVOLVING THE TEL ETV6 GENE/, Leukemia, 11(9), 1997, pp. 1400-1403
Authors:
LACRONIQUE V
VARLET P
MAYEUX P
PORTEU A
GISSELBRECHT S
KAHN A
LACOMBE C
Citation: V. Lacronique et al., BCL-2 TARGETED OVEREXPRESSION INTO THE ERYTHROID LINEAGE OF TRANSGENIC MICE DELAYS BUT DOES NOT PREVENT THE APOPTOSIS OF EPO-DEPRIVED ERYTHROID PROGENITORS, Experimental hematology, 25(8), 1997, pp. 78-78
Authors:
LACRONIQUE V
VARLET P
MAYEUX P
PORTEU A
GISSELBRECHT S
KAHN A
LACOMBE C
Citation: V. Lacronique et al., BCL-2 TARGETED OVEREXPRESSION INTO THE ERYTHROID LINEAGE OF TRANSGENIC MICE DELAYS BUT DOES NOT PREVENT THE APOPTOSIS OF ERYTHROPOIETIN-DEPRIVED ERYTHROID PROGENITORS, Blood, 90(8), 1997, pp. 3050-3056
Authors:
LACRONIQUE V
MIGNON A
FABRE M
VIOLLET B
ROUQUET N
MOLINA T
PORTEU A
HENRION A
BOUSCARY D
VARLET P
JOULIN V
KAHN A
Citation: V. Lacronique et al., BCL-2 PROTECTS FROM LETHAL HEPATIC APOPTOSIS INDUCED BY AN ANTI-FAS ANTIBODY IN MICE, Nature medicine, 2(1), 1996, pp. 80-86
Citation: T. Soussi et V. Lacronique, NEW MURINE MODELS FOR THE STUDY OF THE TU MOR-SUPPRESSOR GENE P53, MS. Medecine sciences, 12(2), 1996, pp. 215-221
Citation: A. Mignon et V. Lacronique, GENE-THERAPY FOR FULMINANT-HEPATITIS - PR OTECTION WITH A BCL-2 TRANSGENE AGAINST FAS SYSTEM-INDUCED HEPATIC APOPTOSIS, MS. Medecine sciences, 12(1), 1996, pp. 84-86
Authors:
BIENVENU T
LACRONIQUE V
RAYMONDJEAN M
CAZENEUVE C
HUBERT D
KAPLAN JC
BELDJORD C
Citation: T. Bienvenu et al., 3 NOVEL SEQUENCE VARIATIONS IN THE 5' UPSTREAM REGION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE - 2 POLYMORPHISMS AND ONE PUTATIVE MOLECULAR DEFECT, Human genetics, 95(6), 1995, pp. 698-702
Authors:
SOUBRANE O
LACRONIQUE V
MIQUEROL L
MIGNON A
HOUSSIN D
Citation: O. Soubrane et al., THE ROLE OF INDUCIBLE NO SYNTHASE (INOS) IN THE HYPERDYNAMIC CIRCULATION OF PORTAL-HYPERTENSION, Hepatology, 22(4), 1995, pp. 199-199
Authors:
LACRONIQUE V
MIGNON A
FABRE M
BOUSCARY D
ROUQUET N
JOULIN V
VARLET P
KAHN A
Citation: V. Lacronique et al., BCL-2 PROTECTS FROM LETHAL HEPATIC APOPTOSIS INDUCED BY THE ANTI-FAS ANTIBODY IN MICE, Hepatology, 22(4), 1995, pp. 483-483
Authors:
LACRONIQUE V
LOPEZ S
MIQUEROL L
PORTEU A
KAHN A
RAYMONDJEAN M
Citation: V. Lacronique et al., IDENTIFICATION AND FUNCTIONAL-CHARACTERIZATION OF AN ERYTHROID-SPECIFIC ENHANCER IN THE L-TYPE PYRUVATE-KINASE GENE, The Journal of biological chemistry, 270(25), 1995, pp. 14989-14997